News

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...
Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...
CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S ...
President Trump’s latest tariff threat has targeted a sector that’s already hobbled.
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.
The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...
Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...